Exact Mass: 401.0270726
Exact Mass Matches: 401.0270726
Found 71 metabolites which its exact mass value is equals to given mass value 401.0270726,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
5-Methyldeoxycytidine diphosphate
C10H17N3O10P2 (401.03891619999996)
S-(1,2-Dichlorovinyl)glutathione
C12H17Cl2N3O6S (401.0215082000001)
This compound belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.
Fenoldopam mesylate
C17H20ClNO6S (401.0699810000001)
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Fenoldopam mesylate (SKF-82526) is a D1 receptor agonist and a novel lysine-specific demethylase 1 (LSD1) inhibitor (IC50=0.8974 μM). Fenoldopam mesylate shows anti-hypertensive effects, anti-cancer cell proliferation activity and can induce cells apoptosis[1][2][3].
4-(5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
C16H11ClF3N3O2S (401.02125720000004)
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
S-(1,2-Dichlorovinyl)-glutathione
C12H17Cl2N3O6S (401.0215082000001)
5-Methanesulfonamido-6-(2,4-difluorothiophenyl)-1-indanone
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
Glutathione trisulfide
bemetizide
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic
1-Naphthalenesulfonicacid, 4-[2-(4-hydroxy-1-naphthalenyl)diazenyl]-, sodium salt (1:1)
C20H14N2NaO4S+ (401.05719440000007)
4-(3-BROMO-PHENYL)-2-(4-TERT-BUTYL-PHENOXYMETHYL)-THIAZOLE
C20H20BrNOS (401.04488900000007)
penflutizide
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic
TERT-BUTYL 5-(BENZYLOXY)-3-BROMO-1H-INDOLE-1-CARBOXYLATE
C20H20BrNO3 (401.0626470000001)
ETHYL 7-BROMO-1-CYCLOPROPYL-8-DIFLUOROMETHOXY-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLATE
C16H14BrF2NO4 (401.0074208000001)
TERT-BUTYL 7-(BENZYLOXY)-3-BROMO-1H-INDOLE-1-CARBOXYLATE
C20H20BrNO3 (401.0626470000001)
1-(TERT-BUTYL) 6-METHYL 3-IODO-1H-INDOLE-1,6-DICARBOXYLATE
Adenosine 3′,5′-cyclic monophosphate acetoxymethyl ester
[4-(4-Amino-6-bromo-2-quinazolinyl)-1-piperazinyl]-2-furanylmethanone
trimethyl(2-naphthalen-2-yloxycarbonyloxyethyl)azanium,iodide
C16H20INO3 (401.04878800000006)
clinafloxacin hydrochloride
C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic
2-nitrooxyethyl 2-(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxyacetate
C19H15NO9 (401.07467800000006)
(3S)-(7-Bromo-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionic acid Methyl ester
C18H16BrN3O3 (401.03749660000005)
Triflumidate
C17H14F3NO5S (401.0544750000001)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
disodium,3-[[4-(2-carboxylatoethylcarbamoyl)phenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylate
Sofinicline benzenesulfonate
C16H17Cl2N3O3S (401.0367632000001)
C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist > C73579 - Nicotinic Agonist
Uridine-diphosphate
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
[(2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino]-2-hydroxypropyl]-(phenylmethyl)phosphinic acid
C18H22Cl2NO3P (401.07142920000007)
D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists
4-[1-(4-bromophenyl)-2-nitroethyl]-5-methyl-2-phenyl-1H-pyrazol-3-one
C18H16BrN3O3 (401.03749660000005)
2-[2-Amino-5-(2-bromophenoxy)pyrimidin-4-yl]-5-ethoxyphenol
C18H16BrN3O3 (401.03749660000005)
5-chloro-N-(2-(4-(2-oxopyridin-1(2H)-yl)benzamido)ethyl)thiophene-2-carboxamide
C19H16ClN3O3S (401.0600856000001)
N-Methyl-{4-[2-(7-oxo-6,7-dihydro-8H-[1,3]thiazolo[5,4-E]indol-8-ylidene)hydrazino]phenyl}methanesulfonamide
grixazone A
C18H15N3O6S (401.06815300000005)
A cysteine derivative that is the S-(2-amino-8-formyl-3-oxo-3H-phenoxazin-1-yl) derivative of N-acetyl-L-cysteine.
2-amino-5-[[1-(carboxymethylamino)-3-[(Z)-1,2-dichloroethenyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
C12H17Cl2N3O6S (401.0215082000001)
N-(3-methyl-4-nitro-1,2-oxazol-5-yl)-5-[2-methyl-5-(trifluoromethyl)pyrazol-3-yl]thiophene-2-carboxamide
C14H10F3N5O4S (401.04055760000006)
(5Z)-1-(4-bromophenyl)-5-[(1,2,5-trimethylpyrrol-3-yl)methylidene]-1,3-diazinane-2,4,6-trione
C18H16BrN3O3 (401.03749660000005)
7-[[[5-(2,4-Dimethylanilino)-1,3,4-thiadiazol-2-yl]thio]methyl]-5-thiazolo[3,2-a]pyrimidinone
2-[[5-(3-Chlorophenyl)-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]-1-(3,4-dihydroxyphenyl)ethanone
C19H16ClN3O3S (401.0600856000001)
2-[(5-amino-1,3,4-thiadiazol-2-yl)thio]-N-[3-(diethylsulfamoyl)phenyl]acetamide
N-(5-bromo-2-oxo-3-indolyl)-2-(2,6-dimethylphenoxy)acetohydrazide
C18H16BrN3O3 (401.03749660000005)
4-(2-bromo-4-methylphenyl)-3-[5-(2-furanyl)-1H-pyrazol-3-yl]-1H-1,2,4-triazole-5-thione
3-chloro-1-benzothiophene-2-carboxylic acid [2-oxo-2-(3-oxo-4H-1,4-benzoxazin-6-yl)ethyl] ester
C19H12ClNO5S (401.01246920000006)
2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-(2-nitrophenyl)acetamide
1-[(3aR,4R,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-4-ylethanone
C19H20BrN3O2 (401.07388000000003)
1-[(3aS,4S,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-4-ylethanone
C19H20BrN3O2 (401.07388000000003)
2-[(5E)-5-[(4-hydroxy-3-methoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-2-phenylacetic acid
C19H15NO5S2 (401.03916200000003)
[5-[2-amino-5-(formamidomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl dihydrogen phosphate
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] prop-2-enoate
5-Methyldeoxycytidine 5-(trihydrogen diphosphate)
C10H17N3O10P2 (401.03891619999996)
UDP(3-)
A nucleoside 5-diphosphate(3-) arising from deprotonation of the diphosphate OH groups of uridine 5-diphosphate (UDP); major species at pH 7.3.
Ribavirin 5-diphosphate(3-)
C8H11N4O11P2 (400.98995759999997)
An organophosphate oxoanion resulting from the removal of the three diphosphate OH groups of ribavirin 5-diphosphate. It is the major species at pH 7.3.
3-[(2-amino-8-formyl-3-oxophenoxazin-1-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid
C18H15N3O6S (401.06815300000005)
(4ar,12ar)-1,4a,8,10,11,12a-hexahydroxy-3,12-dioxo-4,5-dihydrotetracene-2-carboximidic acid
C19H15NO9 (401.07467800000006)
(2r)-3-[(2-amino-8-formyl-3-oxophenoxazin-1-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid
C18H15N3O6S (401.06815300000005)
6-[(2e,4e,6e,8e)-9-(3-bromo-1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one
C20H20BrNO3 (401.0626470000001)
6-[9-(3-bromo-1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one
C20H20BrNO3 (401.0626470000001)
[hydroxy([(2r,3s,5r)-3-hydroxy-5-(2-hydroxy-4-imino-5-methylpyrimidin-1-yl)oxolan-2-yl]methoxy)phosphoryl]oxyphosphonic acid
C10H17N3O10P2 (401.03891619999996)